UNSPSC 51313110: Buclizine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C28H33ClN2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58FQD093NU, chemically known as piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-.alpha.-phenylbenzyl)-, dihydrochloride but more generally known as buclizine hydrochloride, which bears US NIH Compound Identifier 6729. European Medicines Agency schedules Buclizine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00889MIG.

UNSPSC 51313110 Buclizine hydrochloride, a Commodity code, shows a significant mismatch between its nominal scope and recent state and local procurement activity. The code nominally identifies a specific antihistamine pharmaceutical, but the single recent opportunity posted under it—Seminole County, Florida's IFB 60459723LAS—solicits Naloxone and safe drug deactivation systems, products unrelated to buclizine's therapeutic class or mechanism. This suggests either a cataloging error in the county's procurement system or a broader category being misclassified at the commodity tier. The opportunity itself reflects public-health demand for opioid-reversal agents and drug-disposal infrastructure rather than motion-sickness or nausea treatment medications.

Seminole County, Florida posted the only recent opportunity identified under this code. The IFB, released June 30, 2026 with a response deadline of July 26, 2023 (note: the date sequence in the source contains an apparent data inconsistency), seeks annual procurement of 1,900 units of Naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option, includes a three-month probationary termination period, and requires E-Verify compliance, drug-free workplace certification, and federal compliance obligations tied to potential FEMA funding. No set-asides or enterprise designations are specified. The code shows minimal recent state and local activity and no clear geographic concentration; the single opportunity does not represent typical buclizine procurement patterns.